Skip to main content
    B

    Biohaven Ltd. (BHVN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NYSE

    $13.24
    -0.56 (-4.06%)

    Market Cap: $2.08B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Biohaven Ltd. (BHVN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Biohaven (BHVN) has a market cap of $2.08B and an enterprise value of $2.25B. Its share count is up 42.74% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 8.08% above the market cap, as debt exceeds cash.

    Market Cap$2.08B
    Enterprise Value$2.25B
    Latest price (Nov 17, 2026)$13.24

    Key Dates

    The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 1, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.27% in the quarter ended Sep 30, 2026 and grew 26.51% a year over 2 years.

    Shares Outstanding151.04M
    Shares Change (YoY)+42.74%
    Shares Change (QoQ)+0.27%
    Share Count Growth (2Y CAGR)+26.51%

    Price Statistics

    The stock is up 59.52% over 52 weeks and trades 1.56% below its 50-day average.

    Beta (1Y)1.37
    52-Week Change+59.52%
    1-Month Change+16.65%
    3-Month Change-6.36%
    6-Month Change+57.81%
    Total Return (1Y)+59.52%
    Total Return (3Y CAGR)-23.94%
    Return vs SPY (1Y)+28.55%
    Max Drawdown (1Y)-41.21%
    Max Drawdown (3Y)-86.96%
    Sharpe Ratio (1Y)0.42
    Correlation with SPY (1Y)0.24
    50-Day Average$13.45
    200-Day Average$12.34
    52-Week Range$8.03 to $18.24
    RSI (14 Days)44.2
    Average Volume (20 Days)3.82M

    Price chart

    Financial Position

    Current assets cover 3.05x current liabilities.

    Current Ratio3.05x
    Quick Ratio3.05x

    Returns and Efficiency

    Return on invested capital is -315.86% over the last 12 months.

    Return on Assets (ROA)-205.81%
    Return on Invested Capital (ROIC)-315.86%
    Return on Capital Employed (ROCE)-261.05%

    Scores

    BHVN has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$960.00K
    Operating Income-$524.48M
    Pretax Income-$541.73M
    Net Income-$542.68M
    EBITDA-$515.06M
    EBIT-$524.48M
    Reported EPS (TTM)-$3.36

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$95.75M
    Total Debt$264.29M
    Net Debt$168.54M
    Net Debt Per Share$1.12
    Working Capital$128.75M
    Shareholder Equity-$98.25M
    Tangible Book Value-$118.04M
    Total Assets$263.68M
    Total Liabilities$361.92M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $642.00K of capital spending, operating cash flow left -$473.17M of free cash flow.

    Operating Cash Flow-$472.53M
    Capital Expenditures$642.00K
    Free Cash Flow-$473.17M
    FCF Per Share-$3.13
    Depreciation and Amortization$9.42M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-71.55%
    Tangible Book Per Share Growth (2Y CAGR)-77.07%

    Revenue and profit by year

    Dividends and Yields

    BHVN does not pay a dividend. Its free cash flow yield is -23.66%.

    FCF Yield-23.66%
    Buyback Yield-18.68%
    Shareholder Yield-18.68%

    Peer Position

    Against 5 similar companies, BHVN has the lowest ROIC.

    ROIC-315.86% vs -28.26% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs +29.89% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About BHVN

    What is BHVN's market cap?

    Biohaven has a market cap of $2.08B. Its enterprise value, which adds debt and subtracts cash, is $2.25B.

    How many shares of BHVN are outstanding?

    Biohaven has 151.04M shares outstanding. The count is up 42.74% from a year earlier.

    Does BHVN pay a dividend?

    No. Biohaven does not pay a dividend.

    How much debt does BHVN have?

    Biohaven has $264.29M of total debt and $95.75M of cash and equivalents, a net debt position of $168.54M.